Topical Imiquimod for Bowen's Disease of the Head and Neck

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2006
* Double blinded, randomized, placebo controlled trial of imiquimod for the treatment of histologically proven Bowens disease of the head and neck. * Null hypothesis: No difference in histologic clearance rates of patients with head or neck Bowens treated with imiquimod versus placebo. * Outcome: Histologic clearance of Bowens disease at T=14 weeks.
Epistemonikos ID: ec3541cc41150e6e6c16c8db63359ee5f8db235b
First added on: Dec 01, 2021